Coherus BioSciences Management to Present at H.C. Wainwright 24th Annual Global Investment Conference
Coherus BioSciences (Nasdaq: CHRS) announced participation in the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Coherus BioSciences (Nasdaq: CHRS) announced participation in the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 10:00 am ET. Senior management will engage in a fireside chat, which will be available via an audio webcast on the company's investor page. Interested parties are encouraged to access the webcast in advance to ensure a timely connection. The archived webcast will be accessible on the Coherus website for 30 days following the event.
Details
News Market Reaction – CHRS
The recorded move for CHRS in the trading session of this news was -0.66%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will participate at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14 at 10:00 am ET.
An audio webcast of the fireside chat will be available on the investor’s page of the Coherus website at https://investors.coherus.com/upcoming-events. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. The webcast will be archived on the Coherus website for 30 days.
Marek Ciszewski, J.D.
SVP, Investor Relations
Coherus BioSciences, Inc.
IR@coherus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.